Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

Why Investors Should Pay Attention to This Value Stock

Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.

Ensign Group (ENSG)

Founded in 1999 and headquartered in San Juan Capistrano, CA, The Ensign Group Inc. provides health care services in the post-acute care continuum, urgent care center and mobile ancillary businesses in the United States.

ENSG sits at a Zacks Rank #2 (Buy), holds a Value Style Score of B, and has a VGM Score of B. Compared to the Medical - Nursing Homes industry's P/E of 26.5X, shares of Ensign Group are trading at a forward P/E of 26.5X. ENSG also has a PEG Ratio of 1.8, a Price/Cash Flow ratio of 25X, and a Price/Sales ratio of 2.1X.

Many value investors pay close attention to a company's earnings as well. For ENSG, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.01 to $5.44 per share for 2024. Per share ENSG boasts an average earnings surprise of 1.4%.

Investors should take the time to consider ENSG for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Ensign Group, Inc. (ENSG):Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research